Danaher Corporation (DHR) Shares Sold by Tredje AP fonden
Tredje AP fonden reduced its holdings in Danaher Corporation (NYSE:DHR) by 18.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 135,001 shares of the conglomerate’s stock after selling 30,297 shares during the period. Tredje AP fonden’s holdings in Danaher Corporation were worth $11,412,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. AGF Investments Inc. grew its holdings in Danaher Corporation by 1.2% in the second quarter. AGF Investments Inc. now owns 263,238 shares of the conglomerate’s stock valued at $22,216,000 after purchasing an additional 3,149 shares during the period. IFM Investors Pty Ltd acquired a new stake in Danaher Corporation in the second quarter valued at approximately $1,441,000. Dillon & Associates Inc. grew its holdings in Danaher Corporation by 12.5% in the second quarter. Dillon & Associates Inc. now owns 39,332 shares of the conglomerate’s stock valued at $3,304,000 after purchasing an additional 4,376 shares during the period. Polaris Greystone Financial Group LLC grew its holdings in Danaher Corporation by 1.2% in the second quarter. Polaris Greystone Financial Group LLC now owns 235,824 shares of the conglomerate’s stock valued at $19,901,000 after purchasing an additional 2,835 shares during the period. Finally, Fiduciary Trust Co. grew its holdings in Danaher Corporation by 16.8% in the second quarter. Fiduciary Trust Co. now owns 13,727 shares of the conglomerate’s stock valued at $1,158,000 after purchasing an additional 1,971 shares during the period. 75.69% of the stock is currently owned by institutional investors.
Several analysts have commented on the company. Morgan Stanley reissued an “overweight” rating and issued a $95.00 price objective (up from $86.00) on shares of Danaher Corporation in a report on Friday, October 6th. Cowen and Company reissued a “buy” rating and issued a $90.00 price objective on shares of Danaher Corporation in a report on Wednesday, October 4th. Wells Fargo & Company assumed coverage on Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective on the stock. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $83.00 price objective on shares of Danaher Corporation in a report on Tuesday, September 26th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $92.62.
WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.watchlistnews.com/danaher-corporation-dhr-shares-sold-by-tredje-ap-fonden/1624955.html.
Shares of Danaher Corporation (NYSE:DHR) opened at 86.96 on Thursday. The firm has a market capitalization of $60.41 billion, a price-to-earnings ratio of 27.76 and a beta of 1.03. The stock has a 50 day moving average price of $85.55 and a 200-day moving average price of $84.19. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same quarter in the prior year, the company posted $0.90 EPS. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, analysts anticipate that Danaher Corporation will post $3.96 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is presently 17.83%.
In other Danaher Corporation news, insider William King sold 43,688 shares of the stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the transaction, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. In the last three months, insiders have sold 71,496 shares of company stock worth $5,916,223. Corporate insiders own 12.20% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.